Biotech ETF Investing is Starting to Look Good – Here’s Why

The SPDR S&P Biotech ETF (NYSEArca: XBI), one of the largest biotechnology exchange traded funds, is getting in on the sector’s resurgence. XBI, an equal-weight fund, is up about 7% over the past week, bringing its year-to-date gain to over 36%. Biotech ETFs soared even after it became...